Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer–Mediated Cytotoxicity
Antoun Al Absi, Hannah Wurzer, Coralie L. Guérin, et al.
Cancer Research (2018) Vol. 78, Iss. 19, pp. 5631-5643
Open Access | Times Cited: 115

Showing 26-50 of 115 citing articles:

Actin regulators in cancer progression and metastases: From structure and function to cytoskeletal dynamics
Guy Biber, Aviad Ben‐Shmuel, Batel Sabag, et al.
International review of cell and molecular biology (2020), pp. 131-196
Closed Access | Times Cited: 33
Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis
Yu Li, Jordan S. Orange
PLoS Biology (2021) Vol. 19, Iss. 8, pp. e3001328-e3001328
Open Access | Times Cited: 28
Cancer as a biophysical disease: Targeting the mechanical-adaptability program
Ly T.S. Nguyen, Mark Allan C. Jacob, Eleana Parajón, et al.
Biophysical Journal (2022) Vol. 121, Iss. 19, pp. 3573-3585
Open Access | Times Cited: 20
Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migrationviaregulation of the DLC1/TCTP/Cdc42 pathway
Junying Gao, Fengqiu Ma, Wang Xing-jie, et al.
Food & Function (2020) Vol. 11, Iss. 11, pp. 9573-9584
Closed Access | Times Cited: 30
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
Nourhan Hassan, Niklas Rutsch, Balázs Győrffy, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 24
Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
Chenglong Li, Fangkun Liu, Lun‐Quan Sun, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Resisting T cell attack: tumor-cell-intrinsic defense and reparation mechanisms
Brienne McKenzie, Salvatore Valitutti
Trends in cancer (2022) Vol. 9, Iss. 3, pp. 198-211
Open Access | Times Cited: 18
Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes
Brienne McKenzie, Roxana Khazen, Salvatore Valitutti
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Pericyte–Glioblastoma Cell Interaction: A Key Target to Prevent Glioblastoma Progression
Ana Pombero, Raquel García‐López, Salvador Martı́nez
Cells (2023) Vol. 12, Iss. 9, pp. 1324-1324
Open Access | Times Cited: 10
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells
Yingqi Liu, Xuemei Yao, Youbo Zhao, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113213-113213
Open Access | Times Cited: 9
Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity
Tatiana S. Gerashchenko, A. A. Frolova, М. Р. Патышева, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 3
Mechanisms and therapeutic potential of disulphidptosis in cancer
Yanhu Li, Haijun Zhang, Fengguang Yang, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 3
Novel facets of glioma invasion
Carina Fabian, Mingzhi Han, Rolf Bjerkvig, et al.
International review of cell and molecular biology (2020), pp. 33-64
Closed Access | Times Cited: 26
Escape of tumor cells from the NK cell cytotoxic activity
Claudia Cantoni, Hannah Wurzer, Clément Thomas, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 4, pp. 1339-1360
Closed Access | Times Cited: 24
Targeting HDL in tumor microenvironment: New hope for cancer therapy
Tanjun Zhao, Neng Zhu, Ya‐Ning Shi, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 11, pp. 7853-7873
Closed Access | Times Cited: 22
Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer
Alexander Ring, Maria Spataro, Andreas Wicki, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 15
Ultrarapid lytic granule release from CTLs activates Ca 2+ -dependent synaptic resistance pathways in melanoma cells
Liza Filali, Marie-Pierre Puisségur, Kévin Cortacero, et al.
Science Advances (2022) Vol. 8, Iss. 7
Open Access | Times Cited: 14
The mechanobiology of NK cells- ‘Forcing NK to Sense’ target cells
Darren Chen Pei Wong, Jeak Ling Ding
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 2, pp. 188860-188860
Open Access | Times Cited: 8
Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?
Elena Ockfen, Liza Filali, Diogo Pereira Fernandes, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Immunotherapy for glioblastoma: going viral
J. Bryan Iorgulescu, David A. Reardon, E. Antonio Chiocca, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1094-1096
Open Access | Times Cited: 26
NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton
E Hui Clarissa Lee, Darren Chen Pei Wong, Jeak Ling Ding
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
A nano-platform combats the “attack” and “defense” of cytoskeleton to block cascading tumor metastasis
Jing Tao, Yuan Yao, Minyi Huang, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 572-586
Closed Access | Times Cited: 2
Impact of ionizing radiation on cell-ECM mechanical crosstalk in breast cancer
Rocco Mottareale, Crescenzo Frascogna, Giuseppe La Verde, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Inhibition of the Rho/MRTF pathway improves the response of BRAF‐resistant melanoma to PD1/PDL1 blockade
Bardees M. Foda, Sean A. Misek, Kathleen A. Gallo, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 7, pp. 1303-1315
Open Access | Times Cited: 2

Scroll to top